BioAge Labs Stock Forecast

Stock Price Forecast

According to 9 analysts polled by S&P Global, BioAge Labs stock has a consensus rating of "Buy" and an average price target of $49.5. The average 1-year stock price forecast is 138.32% higher than the current stock price, while the lowest is $23 (+10.74%) and the highest is $73 (+251.47%).

Price Target: $49.5 (+138.32%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$23	$49.5	$51	$73
Change	+10.74%	+138.32%	+145.55%	+251.47%

Analyst Ratings

The average analyst rating for BioAge Labs stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jan '26	Feb '26	Mar '26	Apr '26	May '26	Jun '26
Strong Buy	1	3	3	3	5	5
Buy	1	1	2	2	2	2
Hold	3	2	2	2	2	2
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	5	6	7	7	9	9

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Adam Walsh Roth MKM	Roth MKM	Buy Reiterates $36	Buy	Reiterates	$36	+73.33%	Jun 17, 2026
Michael Ulz Morgan Stanley	Morgan Stanley	Hold Maintains $23	Hold	Maintains	$23	+10.74%	Jun 17, 2026
Thomas Shrader BTIG	BTIG	Buy Initiates $40	Buy	Initiates	$40	+92.59%	May 13, 2026
Andy Hsieh William Blair	William Blair	Hold Reiterates n/a	Hold	Reiterates	n/a	n/a	May 11, 2026
Joseph Stringer Needham	Needham	Buy Maintains $50	Buy	Maintains	$50	+140.73%	May 11, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

54.29M

from 9.00M

503.61%

from 9.00M

Revenue Next Year

35.42M

from 54.29M

-34.76%

from 54.29M

EPS This Year

-2.49

from -2.24

EPS Next Year

-2.06

from -2.49

Fiscal Year	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	-	-	-	9.00M	54.29M
Revenue Growth	-	-	-	-	503.61%
Operating Income	-39.97M	-48.40M	-78.19M	-92.78M	-62.88M
Net Income	-39.72M	-63.85M	-71.11M	-80.61M	-58.37M
EPS	-	-	-	-2.24	-2.49
Free Cash Flow	-	-27.91M	-34.21M	-54.84M	130.50M
No. Analysts	-	-	-	-	10

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	483.8M
Avg	54.3M
Low	2.8M

Revenue Growth

Revenue Growth	2026	2027	2028
High	5,278.5%
Avg	503.6%
Low	-69.2%

EPS Forecast

EPS	2026	2027	2028
High	-2.12
Avg	-2.49
Low	-3.03

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-